In retrospect—even though Army life was not for me—going to France was a unique opportunity for a young man to gain perspective on the culture of Western Europe. With my 2-year “vacation” at an end, I was ready to focus on my future in ophthalmology.
As part of Ophthalmology Times’ coverage of the 14th EURETINA Congress in London this week, Group Content Director Mark L. Dlugoss writes this blog.
In part 3 of our discussion on patient adherence, Dermatology Times editorial advisor, Dr. Elaine Siegfried, continues the discussion with Dr. Steven Feldman on assessing adherence and intervening to encourage the best possible treatment outcomes. They discuss a method for developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area. Dr. Feldman is a professor of dermatology at the Wake Forest University School of Medicine.
On September 9, Apple revealed the Apple Watch, saying it can help people lead healthier lives. It joins a growing list of new health innovations including Health and HealthKit, set launch in September.
One expert points to an example of how looks can deceive when deciding whether to treat skin rashes in pediatric patients undergoing cancer treatment.